Mechanistic studies of transcription initiation and elongation functions of an RNA polymerase II variant, Pol II(G), that is implicated in development and cancer
RNA 聚合酶 II 变体 Pol II(G) 的转录起始和延伸功能的机制研究,该变体与发育和癌症有关
基本信息
- 批准号:10670981
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-25 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAlbuminsBindingBiochemicalBiologicalBiological AssayBreast Cancer CellBreast CarcinomaCancer Cell GrowthCarcinomaCell CycleCell Differentiation processCell LineCellsChIP-seqChromatinComplementComplexCryoelectron MicroscopyDevelopmentDown-RegulationElongation FactorEmbryoEmbryonic DevelopmentEnhancersEventExperimental DesignsGene ActivationGenesGeneticGenetic TranscriptionGenetic studyGrowthHep3BHepatocarcinogenesisHepatocyteHumanImmobilizationIn VitroIndividualInterventionLiverMaintenanceMalignant NeoplasmsMass Spectrum AnalysisMediatingMediatorModelingMolecular Mechanisms of ActionMusPathologyPeptide Initiation FactorsPhysiologicalPhysiological ProcessesPlayPolymerasePrimary carcinoma of the liver cellsProcessProductivityPropertyProteinsRNA Polymerase IIRecombinantsRegulationRepressionRoleSignal PathwaySiteStructureTP53 geneTherapeuticTissuesTranscription CoactivatorTranscription ElongationTranscription Factor TFIIBTranscription InitiationTranscriptional Elongation FactorsTranscriptional RegulationVariantYeastscancer cellcell growthcofactorembryonic stem cellflygene repressionhuman diseaseinsightlipid metabolismliver developmentmalignant breast neoplasmmultiple omicsnegative elongation factornovelp53 Signaling Pathwaypancreatic differentiation 2 proteinpolypeptidepremalignantpreventprogramspromoterreconstitutionrecruittranscription factortranscription factor S-IItranscription factor TFIIF
项目摘要
Eukaryotic RNA polymerase II (Pol II) plays a pivotal role in transcription. Normal physiological processes
depend upon precise transcriptional controls, whereas transcriptional dysregulation is the basis of numerous
pathologies that include cancer. Pol II recruitment to specific promoters is regulated by multiple cofactors that
include the multi-subunit Mediator, which directly binds both to enhancer/promoter-bound
transcriptional activators and to Pol II to facilitate gene activation. Following initiation and promoter escape,
Pol II remains subject to regulation by multiple elongation factors, acting either at Pol II pause-release or
productive elongation steps. Pol II(G) is a recently described form of Pol II that contains the tightly
associated, metazoan-specific Gdown1 polypeptide along with the normal 12 subunits. Our genetic-
based studies of Pol II(G) have demonstrated that Gdown1 is essential for early embryonic development
and for cell-specific transcription in quiescent hepatocytes, in which heavy localization to gene bodies of
highly expressed liver-specific genes (e.g., albumin) is indicative of elongation functions and in which ablation
leads to downregulation of both liver-specific and lipid metabolism genes, cell cycle re-entry and (in the
absence of p53) a premalignant type of transformation. Studies in hepatocarcinoma and breast cancer cells
have also indicated a key role for Gdown1 in cell growth and in expression of lipid metabolism genes, which
are generally important for maintenance of cancer cell growth. Our biochemical studies have revealed that
the Pol II-associated Gdown1 conditionally represses basal (activator- and Mediator-independent)
transcription initiation by preventing association of TFIIB and TFIIF with Pol II, thereby establishing a potential
checkpoint and eliciting a strong requirement for activator-bound Mediator to overcome repression. Our
structural studies have defined Gdown1 interaction sites on Pol II and provided clues regarding Mediator
interactions that might facilitate its reversal of the conditionally repressed initiation capacity of Pol II(G),
although the underlying mechanism remains unclear. With the general objective of understanding the
molecular mechanisms of action of Pol II(G) in conjunction with its roles in breast cancer and hepatocarcinoma
cells, especially on Gdown1-regulated cell-specific and lipid metabolism genes, as a potential basis for new
cancer therapeutics, our specific aims are: (i) to investigate the mechanisms underlying Mediator-dependent
transcription initiation and post-initiation events by Pol II(G), including concomitant, newly described
interactions with general transcription factors and elongation factor TFIIS, using powerful in vitro transcription
and immobilized template assays and CX-MS and cryo-EM structural analyses of interacting complexes and (ii)
to investigate Gdown1 functions in hepatocarcinoma cells in promoter-proximal pausing, pause release and
transcriptional processivity using (a) a multiomics cell-based approach in conjunction with acute degradation of
Gdown1 and (b) biochemical (in vitro reconstitution of these processes with purified factors and recombinant
chromatin templates) and structural (CX-MS and cryo-EM) analyses of Pol II(G) elongation factor complexes.
真核细胞RNA聚合酶II(POL II)在转录过程中起着关键作用。正常生理过程
依赖于精确的转录控制,而转录失调是许多
包括癌症在内的病理学。POL II招募到特定推动者受到多个辅助因素的调节,这些辅助因素
包括直接与增强子/启动子结合的多亚基介体
转录激活剂和Pol II促进基因激活。在启动和启动子逃逸之后,
POL II仍然受到多个伸长因素的调节,在POL II暂停释放或
富有成效的延伸步骤。POL II(G)是最近描述的POL II的形式,它包含
相关的后生动物特异性Gdown 1多肽以及正常的12个亚基。我们的基因-
对POL II(G)的基础研究表明,Gdown 1对早期胚胎发育是必不可少的
在静止的肝细胞中进行细胞特异性转录,其中大量定位于基因体。
高表达的肝脏特异性基因(例如,白蛋白)是延长功能的指标,在这种情况下,消融
导致肝脏特异性和脂代谢基因的下调,细胞周期重新进入和(在
P53缺失)是一种癌前类型的转化。关于肝癌和乳腺癌细胞的研究
也表明Gdown 1在细胞生长和脂代谢基因的表达中发挥关键作用,
通常对维持癌细胞的生长很重要。我们的生化研究显示
POL II相关的Gdown 1有条件地抑制基础(激活物和介体非依赖)
通过阻止TFIIB和TFIIF与POL II结合而启动转录,从而建立潜在的
检查点,并引发了对激活器绑定的调解人的强烈需求,以克服压制。我们的
结构研究已经确定了POL II上的Gdown 1相互作用位点,并提供了关于介体的线索
可能有助于其逆转Pol II(G)有条件抑制的启动能力的相互作用,
尽管潜在的机制尚不清楚。总的目标是理解
Pol II(G)作用的分子机制及其在乳腺癌和肝癌中的作用
细胞,特别是Gdown-1调控的细胞特异性和脂代谢基因,作为新的潜在基础
癌症治疗学,我们的具体目标是:(I)研究介体依赖的潜在机制
Pol II(G)的转录启动和启动后事件,包括伴随事件,新描述
与普通转录因子和延伸因子TFIIS的相互作用,使用强大的体外转录
和固定化模板分析以及相互作用络合物的CX-MS和冷冻-EM结构分析和(II)
研究Gdown 1在启动子-近端暂停、暂停释放和
使用(A)以细胞为基础的多组学方法结合急性降解的转录过程
Gdown 1和(B)生化(用纯化因子和重组人在体外重建这些过程
(染色质模板)和结构(CX-MS和冷冻-EM)分析POL II(G)延伸因子复合体。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT G ROEDER其他文献
ROBERT G ROEDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT G ROEDER', 18)}}的其他基金
Mechanistic studies of transcription initiation and elongation functions of an RNA polymerase II variant, Pol II(G), that is implicated in development and cancer
RNA 聚合酶 II 变体 Pol II(G) 的转录起始和延伸功能的机制研究,该变体与发育和癌症有关
- 批准号:
10503451 - 财政年份:2022
- 资助金额:
$ 38万 - 项目类别:
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
转录共激活因子 OCA-B 在 B 细胞发育和淋巴瘤发生中的功能和机制
- 批准号:
10303052 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Molecular mechanisms of estrogen receptor-dependent transcription regulation
雌激素受体依赖性转录调控的分子机制
- 批准号:
10545758 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Molecular mechanisms of estrogen receptor-dependent transcription regulation
雌激素受体依赖性转录调控的分子机制
- 批准号:
10322679 - 财政年份:2019
- 资助金额:
$ 38万 - 项目类别:
Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G)
RNA聚合酶II(G)的生物学作用和介体依赖性转录机制
- 批准号:
9009066 - 财政年份:2015
- 资助金额:
$ 38万 - 项目类别:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
B 细胞发育和白血病发生中的转录调控机制
- 批准号:
8564107 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
B 细胞发育和白血病发生中的转录调控机制
- 批准号:
8719062 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
B 细胞发育和白血病发生中的转录调控机制
- 批准号:
9271811 - 财政年份:2013
- 资助金额:
$ 38万 - 项目类别:
Function and targeting of a stable transcription factor complex in leukemia
白血病中稳定转录因子复合物的功能和靶向
- 批准号:
8513945 - 财政年份:2011
- 资助金额:
$ 38万 - 项目类别:
Function and targeting of a stable transcription factor complex in leukemia
白血病中稳定转录因子复合物的功能和靶向
- 批准号:
8163071 - 财政年份:2011
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Standard Grant